Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for Her2-Positive Breast Cancer
AuthID
P-00Y-N89
P-00Y-N89
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service